The ESR Stat Plus can read the erythrocyte sedimentation rate (ESR) of a person’s blood within minutes. Now that medical institutions are looking for more resources to test patient ESRs, the ESR Stat Plus serves as one of the many products available for those who need it to test for diseases like rheumatoid arthritis. Experts are saying that rheumatoid arthritis test kit markets will be valued at around $787.7 million by the last quarter of 2022. These types of tests are divided into categories such as serology and treatment monitoring. The reason for the expected rise is due to the expected increase in occurrences of autoimmune diseases, as well as more prescriptions of off-label NSAIDs (non-steroidal anti-inflammatory drugs) and other pain medications, since use of these medications must be monitored. In terms of geographic location, the tests' markets are distributed among North America, Europe, Asia Pacific, Latin America, Africa, and the Middle East. Around 60% of 2015's revenue came from Europe and the Asia Pacific region. North America, the area in which rheumatoid arthritis is most prevalent, tends to be less profitable due to increased awareness of the disease and healthcare accessibility for therapy and treatment.
0 Comments
Leave a Reply. |
AuthorESR Stat Plus Archives
June 2017
Categories
All
|